Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes
Authors:
- Sevgi GungorSGSevgi Gungor
- Alper OkyarAOAlper Okyar
- Sidika Erturk-TokerSESidika Erturk-Toker
- Gul BaktirGBGul Baktir
- Yildiz OzsoyYOYildiz Ozsoy
- 6 February 2010
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 36 (7) , 806-813
Abstract
Background: The aim of this study was to develop chitosan microspheres for nasal delivery of ondansetron hydrochloride (OND). Method: Microspheres were prepared with spray-drying method using glutaraldehyde as the crosslinking agent. Microspheres were characterized in terms of morphology, particle size, zeta potential, production yield, drug content, encapsulation efficiency, and in vitro drug release. Results: All microspheres were spherical in shape with smooth surface and positively charged. Microspheres had also high encapsulation efficiency and the suitable particle size for nasal administration. In vitro studies indicated that all crosslinked microspheres had a significant burst effect, and sustained drug release pattern was observed until 24 hours following burst drug release. Nasal absorption of OND from crosslinked chitosan microspheres was evaluated in rats, and pharmacokinetic parameters of OND calculated from nasal microsphere administration were compared with those of both nasal and parenteral administration of aqueous solutions of OND. In vivo data also supported that OND-loaded microspheres were also able to attain a sustained plasma profile and significantly larger area under the curve values with respect to nasal aqueous solution of OND. Conclusion: Based on in vitro and in vivo data, it could be concluded that crosslinked chitosan microspheres are considered as a nasal delivery system of OND.Keywords
This publication has 29 references indexed in Scilit:
- Formulation and evaluation of ondansetron nasal delivery systemsInternational Journal of Pharmaceutics, 2008
- Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studiesJournal of Pharmacy and Pharmacology, 2005
- Mucoadhesive Microspheres for Controlled Drug DeliveryBiological and Pharmaceutical Bulletin, 2004
- The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humansAdvanced Drug Delivery Reviews, 2002
- Nasal absorption of ondansetron in rats: an alternative route of drug deliveryCancer Chemotherapy and Pharmacology, 2000
- Anatomy, physiology and function of the nasal cavities in health and diseaseAdvanced Drug Delivery Reviews, 1998
- 5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and VomitingDrugs, 1998
- Physiology of Chemotherapy-Induced Emesis and Antiemetic TherapyDrugs, 1997
- OndansetronDrugs, 1996
- Ondansetron Clinical PharmacokineticsClinical Pharmacokinetics, 1995